A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms. [PDF]
J Parkinsons DisMoreau C +6 more
europepmc +1 more source
Preoperative Functional Connectivity Predicts Antiparkinson Drug Change after Deep Brain Stimulation. [PDF]
Mov DisordMikhael D +9 more
europepmc +1 more source
Comparison of blood dopamine in Parkinson's patients treated with levodopa carbidopa entacapone vs levodopa benserazide: A randomized controlled trial. [PDF]
Medicine (Baltimore)Korucu O +4 more
europepmc +1 more source
Quantitative Operational Monitoring for BDI Agents
Belief-Desire-Intention (BDI) architecture is a popular framework for designing autonomous systems. As these systems make independent decisions and execute actions independent from humans, ensuring their safety and reliability becomes a major concern ...
Ferrando A., Xu M., Farrell M.
core
Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review. [PDF]
J Parkinsons DisBeckers M +5 more
europepmc +1 more source
COMPARISON OF THE ELECTROENCEPHALOGRAPHIC AND MOTOR EFFECTS OF ORPHENADRINE, AN ANTIPARKINSON AGENT
Japanese Journal of Pharmacology, 1968 BAN, TAKASHI, HOJO, MASAKAZU
openaire +3 more sources
Vertebrobasilar dolichoectasia compresses midbrain, worsens Parkinson symptoms, and evokes Holmes tremor: A case report. [PDF]
Medicine (Baltimore)Li J, Cheng N, Liu T, Rong Q.
europepmc +1 more source
Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report. [PDF]
BMC NeurolZang P, Liu Y, Hao Y.
europepmc +1 more source
Is continuous dopaminergic delivery still a major goal to be achieved in the treatment of Parkinson's disease? [PDF]
J Parkinsons DisDi Lazzaro G +4 more
europepmc +1 more source